{
    "nctId": "NCT01351844",
    "briefTitle": "The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer",
    "officialTitle": "Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer, Arthralgia",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 12,
    "primaryOutcomeMeasure": "Feasibility",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Post-menopausal stage I-III breast cancer patients\n* Starting or about to start aromatase inhibitor\n* English speaking with ability to read, write and use a computer to watch and listen to an educational module.\n* Able to give informed consent\n\nExclusion Criteria:\n\n* Aromatase inhibitor (AI) use for more than 6 months\n* Metastatic breast cancer\n* Non-English speaking, or unable to read, write or use a computer to watch and listen to an educational module.\n* Unable to give informed consent",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}